[1]
Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S. 2001. Oxidative damage is the earliest event in Alzheimer disease. J. of Neuropathol. Exp. Neurol., 60(8), 759-767.
[2]
Smith, M.A.; Harris, P.L.R.; Sayre, L.M.; Beckman, J.S.; Perry, G. 1997. Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J. of Neurosci., 17(8), 2653-2657.
[3]
Smith, M.A.; Harris, P.L.; Sayre, L.M.; Perry, G. 1997. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proceedings of the National Academy of Sciences,, 94(18), 9866-9868.
[4]
Smith, M.A.; Rottkamp, C.A.; Nunomura, A.; Raina, A.K.; Perry, G. 2000. Oxidative stress in Alzheimer’s disease. Biochimica et Biophysica
Acta (BBA)-Molecular Basis of Disease, 1502(1), pp. 139-144.
[5]
Sayre, L.M.; Zelasko, D.A.; Harris, P.L.; Perry, G.; Salomon, R.G.; Smith, M.A. 1997. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J. of Neurochem., 68(5), 2092-2097.
[6]
Smith, M.A.; Taneda, S.; Richey, P.L.; Miyata, S.; Yan, S.D.; Stern, D.; Sayre, L.M.; Monnier, V.M.; Perry, G. 1994. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proceedings of the National Academy of Sciences,, 91(12), 5710-5714.
